AI assistant
Sending…
TransUnion — Director's Dealing 2021
Dec 21, 2021
30359_dirs_2021-12-21_c63f3983-b319-4456-abf3-9941827a9967.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransUnion (TRU)
CIK: 0001552033
Period of Report: 2021-12-17
Reporting Person: WOJCZYNSKI DAVID E (Former President, Healthcare)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-17 | Common Stock | F | 5265 | $110.76 | Disposed | 27447.824 | Direct |
Footnotes
F1: Reflects shares of Common Stock withheld by the Company in payment of tax liability incident to the vesting of restricted stock units granted on February 20, 2019, February 21, 2020 and February 19, 2021. The vesting of such restricted stock units was accelerated in connection with the divestiture of TransUnion's Healthcare business on December 17, 2021.
F2: Includes 260.824 shares of common stock acquired pursuant to the issuer's employee stock purchase plan since the reporting person's last report.
More from TransUnion
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3